logo

PD Dr.
Annabel Graser

Уролог - специализируется на уро-онкологии

Werdegang

  • 2006 - 2012

    Studium der Humanmedizin an der LMU und TU, München

  • 2013

    Promotion als Doktorin der Medizin, Charité Berlin

  • 2013 - 2018

    Assistenzärztin, Klinik für Urologie, Klinikum Meiningen GmbH, Meiningen und
    Klinik für Urologie, LMU Klinikum, München

  • 2018

    Anerkennung zur Fachärztin für Urologie

  • 2018

    Zusatzbezeichnung: Medikamentöse Tumortherapie

  • 2018 - 2024

    Funktionsoberärztin, Klinik für Urologie, LMU Klinikum München

  • 2022

    Habilitation an der LMU München

Mitgliedschaften

  • Aktuell

    Deutsche Gesellschaft für Urologie (DGU)

  • Aktuell

    European Association of Urology (EAU)

  • Aktuell

    UroEvidence, Reviewboard der DGU

публикации

  • 19/03/2026

    Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC)
    Cancers (Basel)

  • 27/11/2025

    Gyroscopic Radiosurgery - Clinical Experience and Prospective Analysis of over 500 Treated Tumors
    PubMed

  • 02/04/2025

    Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer.
    Urologie (Heidelberg, Germany)

  • 24/03/2025

    Perioperative Outcomes After Radical Nephrectomy with Inferior Vena Cava Thrombectomy.
    Cancers

  • 01/02/2025

    Sex-specific differences in recurrence and progression following cytostatic intravesical chemotherapy for non-muscle invasive urothelial bladder cancer (NMIBC).
    Journal of cancer research and clinical oncology

  • 11/07/2024

    Gender-Specific Differences in Recurrence and Progression following Bacillus Calmette-Guérin Instillation for Non-Muscle-Invasive Bladder Cancer.
    Urologia internationalis

  • 10/04/2024

    [Antidepressants for the treatment of depression in people with cancer].
    Urologie (Heidelberg, Germany)

  • 24/12/2023

    Surgical Trends and Complications in Partial and Radical Nephrectomy: Results from the GRAND Study.
    Cancers

  • 02/11/2023

    Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not Anecdotal.
    Clinical genitourinary cancer

  • 20/04/2023

    Gender-specific outcomes in immune checkpoint inhibitor therapy for advanced or metastatic urothelial cancer: a systematic review and meta-analysis.
    Journal of cancer research and clinical oncology

  • 12/01/2022

    Image-Guided Robotic Radiosurgery for the Treatment of Lung Metastases of Renal Cell Carcinoma-A Retrospective, Single Center Analysis.
    Cancers

  • 08/02/2021

    Safety and Efficacy of Robotic Radiosurgery for Visceral and Lymph Node Metastases of Renal Cell Carcinoma: A Retrospective, Single Center Analysis.
    Cancers

  • 18/06/2020

    Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancers.
    Journal of geriatric oncology